An exploratory, double-blind, randomized, placebo controlled, 2 period cross-over, pharmacokinetic/pharmacodynamic, single center study to asses the effect of AZD6140 on respiratory parameters in mild asthma and mild COPD patients age 55 to 75 years
Study identifier:D5130C00034
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An exploratory, double-blind, randomized, placebo controlled, 2 period cross-over, pharmacokinetic/pharmacodynamic, single center study to asses the effect of AZD6140 on respiratory parameters in mild asthma and mild COPD patients age 55 to 75 years
Medical condition
asthma
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 May 2005
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
